Med-Chemist : "Quintessential Medicinal Chemistry"
Friday, December 13, 2013
First in-human trial of endoxifen shows promise as breast cancer treatment
Estrogen receptor
α
(ER
α
) ligand; potent antiestrogen. Metabolite of
tamoxifen
(Cat. No. 0999). Primary metabolite responsible for the effectiveness of tamoxifen in ER-positive breast cancer...
First in-human trial of endoxifen shows promise as breast cancer treatment
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment